![]() |
Volumn 495, Issue , 2001, Pages 349-354
|
Exosomes in cancer immunotherapy: Preclinical data
a
b
INSTITUT CURIE
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD11B ANTIGEN;
CD63 ANTIGEN;
CD81 ANTIGEN;
CD82 ANTIGEN;
CD9 ANTIGEN;
GAG PROTEIN;
INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;
LIPOCORTIN 2;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
TUMOR PROTEIN;
ADOPTIVE IMMUNOTHERAPY;
ANTIGEN PRESENTATION;
BIOTECHNOLOGY;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
CELL FREE SYSTEM;
CLINICAL TRIAL;
COMPLEX FORMATION;
CONFERENCE PAPER;
DENDRITIC CELL;
EXOSOME;
HUMAN;
MELANOMA;
MEMBRANE COMPONENT;
MEMBRANE VESICLE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN CONTENT;
TREATMENT OUTCOME;
TUMOR CELL CULTURE;
ANIMALS;
ANTIGEN PRESENTATION;
ANTIGENS, NEOPLASM;
CLINICAL TRIALS;
DENDRITIC CELLS;
HISTOCOMPATIBILITY ANTIGENS CLASS I;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
IMMUNOTHERAPY;
MICE;
NEOPLASMS;
ORGANELLES;
T-LYMPHOCYTES, CYTOTOXIC;
|
EID: 18244392686
PISSN: 00652598
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-0685-0_49 Document Type: Article |
Times cited : (35)
|
References (13)
|